Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11654113 Modified release formulations and uses thereof

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Sunovion
Sunovion
0
Date Filed
September 30, 2021
0
Date of Patent
May 23, 2023
0
Patent Applicant
Sunovion
Sunovion
0
Patent Application Number
17490616
0
Patent Citations
‌
US Patent 8263125 Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients
0
‌
US Patent 8268352 Modified release composition for highly soluble drugs
0
‌
US Patent 8304431 Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
0
‌
US Patent 8377994 Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions
0
‌
US Patent 8394790 Psychotropic agents having glutamate NMDA activity
0
‌
US Patent 8480631 Hazardous agent injection system
0
‌
US Patent 8575172 Pharmaceutical compositions of aripiprazole
0
‌
US Patent 8697127 Method for preparing microspheres and microspheres produced thereby
0
‌
US Patent 8876758 Viscous formulations and their use in needle-free injection
0
‌
US Patent 8906847 Prodrug comprising a drug linker conjugate
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11654113
0
Patent Primary Examiner
‌
Bethany P Barham
0

Find more entities like US Patent 11654113 Modified release formulations and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.